Pulmatrix

$1.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (+3.76%) As of 5:18 PM UTC today

Why Robinhood?

You can buy or sell Pulmatrix and other stocks, options, and ETFs commission-free!

About PULM

Pulmatrix, Inc. Common Stock, also called Pulmatrix, is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases.

CEO

Teofilo Raad

Employees

Headquarters

Lexington, Massachusetts

Founded

2015

Market Cap

70.12M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.55M

High Today

$1.05

Low Today

$0.9501

Open Price

$0.96

Volume

984.42K

52 Week High

$3.04

52 Week Low

$0.9095

PULM News

MarketWatchApr 9

Pulmatrix Inc. Stock Quote (U.S.: Nasdaq)

Pulmatrix Inc. Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products

PULM Earnings

-$0.31

-$0.21

-$0.10

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 13, Pre-Market